30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Oric Pharmaceuticals Inc (ORIC)

Track

The most recent insider trading activity occurred on February 24, 2026, with planned and proposed sales by the Chief Financial Officer. Prior to this, in January 2026, a Director engaged in planned and proposed sales. In December 2025, several officers and a Director executed sales and proposed sales, including the Chief Financial Officer and Chief Medical Officer.
Stock chart
Ticker: ORIC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Piscitelli Dominic
Chief Financial Officer
1 sale — total 702,686 USD
Planned sale 24 Feb 2026
Value US$2,800,077.48 | Price 270.02 | Shares 87,002
Proposed sale 24 Feb 2026
Value US$3,466,028.86 | Price 77.52 | Shares 61,467
Planned sale 16 Jan 2026
Value US$38,414.72 | Price 12.00 | Shares 3,200
Planned sale 16 Jan 2026
Value US$42,016.10 | Price 12.00 | Shares 3,500
Proposed sale 16 Jan 2026
Value US$76,800.00 | Price 12.00 | Shares 6,400
Proposed sale 16 Jan 2026
Value US$84,000.00 | Price 12.00 | Shares 7,000
Sale 16 Dec 2025
Value US$97,127.49 | Price 9.06 | Shares 10,720
Proposed sale 16 Dec 2025
Value US$97,128.50 | Price 9.06 | Shares 10,720
Sale 16 Dec 2025
Value US$97,128.56 | Price 9.06 | Shares 10,720
Proposed sale 16 Dec 2025
Value US$97,128.64 | Price 9.06 | Shares 10,720
Sale 16 Dec 2025
Value US$302,368.44 | Price 9.06 | Shares 33,374
Proposed sale 16 Dec 2025
Value US$302,369.66 | Price 9.06 | Shares 33,374
Planned sale 6 Oct 2025
Value US$461,519.52 | Price 12.32 | Shares 37,461
Planned sale 6 Oct 2025
Value US$159,718.90 | Price 14.52 | Shares 11,000
Proposed sale 6 Oct 2025
Value US$725,000.00 | Price 14.50 | Shares 50,000
Planned sale 1 Oct 2025
Value US$638,805.15 | Price 12.05 | Shares 53,001
Planned sale 30 Sep 2025
Value US$414,749.57 | Price 12.01 | Shares 34,538
Planned sale 22 Sep 2025
Value US$1,349,937.50 | Price 10.80 | Shares 125,000
Proposed sale 22 Sep 2025
Value US$2,625,000.00 | Price 10.50 | Shares 250,000
Planned sale 1 Jul 2025
Value US$200,972.00 | Price 10.05 | Shares 20,000
Planned sale 24 Jun 2025
Value US$341,039.10 | Price 10.50 | Shares 32,466
Planned sale 23 Jun 2025
Value US$4,504.50 | Price 10.01 | Shares 450
Planned sale 23 Jun 2025
Value US$5,840.00 | Price 10.00 | Shares 584
Buy 23 Jun 2025
Value US$13,230.29 | Price 9.43 | Shares 1,403
Buy 20 Jun 2025
Value US$249,668.70 | Price 9.39 | Shares 26,597
Planned sale 12 Jun 2025
Value US$3,000.00 | Price 10.00 | Shares 300
Planned sale 11 Jun 2025
Value US$17,017.00 | Price 10.01 | Shares 1,700
Planned sale 11 Jun 2025
Value US$12,760.00 | Price 10.00 | Shares 1,276
Planned sale 10 Jun 2025
Value US$3,240.00 | Price 10.00 | Shares 324
Planned sale 9 Jun 2025
Value US$3,000.00 | Price 10.00 | Shares 300
Planned sale 6 Jun 2025
Value US$26,021.32 | Price 10.01 | Shares 2,600
Proposed sale 6 Jun 2025
Value US$540,000.00 | Price 9.00 | Shares 60,000
Sale 16 Dec 2024
Value US$73,297.79 | Price 8.28 | Shares 8,851
Proposed sale 16 Dec 2024
Value US$73,298.14 | Price 8.28 | Shares 8,851
Sale 16 Dec 2024
Value US$73,293.04 | Price 8.28 | Shares 8,850
Proposed sale 16 Dec 2024
Value US$73,293.64 | Price 8.28 | Shares 8,850
Sale 16 Dec 2024
Value US$204,214.39 | Price 8.28 | Shares 24,660
Proposed sale 16 Dec 2024
Value US$204,214.55 | Price 8.28 | Shares 24,660
Planned sale 6 Mar 2024
Value US$648,380.00 | Price 16.21 | Shares 40,000
Proposed sale 6 Mar 2024
Value US$648,380.00 | Price 16.21 | Shares 40,000
Planned sale 7 Feb 2024
Value US$320,186.39 | Price 12.30 | Shares 26,042
Planned sale 6 Feb 2024
Value US$169,159.79 | Price 12.12 | Shares 13,958
Proposed sale 6 Feb 2024
Value US$480,000.00 | Price 12.00 | Shares 40,000
Sale 15 Dec 2023
Value US$124,812.95 | Price 8.58 | Shares 14,539
Sale 15 Dec 2023
Value US$45,338.05 | Price 8.58 | Shares 5,282
Sale 15 Dec 2023
Value US$45,350.72 | Price 8.59 | Shares 5,282
Planned sale 11 Jul 2023
Value US$41,287.19 | Price 8.01 | Shares 5,156
Planned sale 10 Jul 2023
Value US$84,212.16 | Price 8.01 | Shares 10,508
Planned sale 5 Jul 2023
Value US$34,710.55 | Price 8.01 | Shares 4,336
Proposed sale 5 Jul 2023
Value US$160,000.00 | Price 8.00 | Shares 20,000
Planned sale 26 Jun 2023
Value US$160,562.00 | Price 8.03 | Shares 20,000
Proposed sale 26 Jun 2023
Value US$160,561.00 | Price 8.03 | Shares 20,000
Sale 15 Dec 2022
Value US$6,789.25 | Price 3.25 | Shares 2,089
Sale 15 Dec 2022
Value US$6,789.25 | Price 3.25 | Shares 2,089
Sale 15 Dec 2022
Value US$18,733.00 | Price 3.25 | Shares 5,764
Buy 13 May 2022
Value US$214,561.08 | Price 2.82 | Shares 76,072
Buy 12 May 2022
Value US$190,466.89 | Price 2.75 | Shares 69,354
Buy 11 May 2022
Value US$883,569.17 | Price 2.90 | Shares 304,574
Buy 25 Mar 2022
Value US$227,170.00 | Price 4.54 | Shares 50,000
Buy 24 Mar 2022
Value US$215,659.76 | Price 5.03 | Shares 42,873
Buy 23 Mar 2022
Value US$1,280,878.15 | Price 4.98 | Shares 257,127
Planned sale 13 Sep 2021
Value US$70,088.86 | Price 25.02 | Shares 2,801
Planned sale 13 Sep 2021
Value US$15,032.99 | Price 25.01 | Shares 601
Planned sale 10 Sep 2021
Value US$73,783.30 | Price 25.08 | Shares 2,942
Planned sale 10 Sep 2021
Value US$12,023.14 | Price 25.10 | Shares 479
Planned sale 27 May 2021
Value US$10,028.00 | Price 25.07 | Shares 400
Planned sale 24 May 2021
Value US$2,500.00 | Price 25.00 | Shares 100
Planned sale 24 May 2021
Value US$300.00 | Price 25.00 | Shares 12
Planned sale 21 May 2021
Value US$31,008.27 | Price 25.19 | Shares 1,231
Planned sale 21 May 2021
Value US$120,687.88 | Price 25.20 | Shares 4,790
Planned sale 20 May 2021
Value US$16,528.05 | Price 25.08 | Shares 659
Planned sale 20 May 2021
Value US$61,863.88 | Price 25.07 | Shares 2,468
Planned sale 18 May 2021
Value US$5,206.00 | Price 26.03 | Shares 200
Planned sale 18 May 2021
Value US$282,427.75 | Price 25.37 | Shares 11,132
Planned sale 18 May 2021
Value US$54,715.44 | Price 25.32 | Shares 2,161
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-24 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
87,002 +20.9%
270.02
US$2,800,077 		87,002 +20.9% 270.02 US$2,800,077
2026-02-24 2026-02-24 PrS Proposed sale
2.2
Dominic Piscitelli

Officer

Officer
61,467
77.52
US$3,466,029 		61,467 77.52 US$3,466,029
2026-01-20 2026-01-16 PlS Planned sale
Heyman Richard A.
Non-Executive Director
70,514 +1.2%
239.16
US$3,818,219 		70,514 +1.2% 239.16 US$3,818,219
2026-01-20 2026-01-16 PlS Planned sale
Heyman Richard A.
Non-Executive Director
3,500 -7.7%
12.00
US$42,016 		3,500 -7.7% 12.00 US$42,016
2026-01-16 2026-01-16 PrS Proposed sale
Richard A, Heyman

Director

Non-Executive Director
6,400
12.00
US$76,800 		6,400 12.00 US$76,800
2026-01-16 2026-01-16 PrS Proposed sale
Richard A, Heyman

Director

Non-Executive Director
7,000
12.00
US$84,000 		7,000 12.00 US$84,000
2025-12-17 2025-12-16 S Sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
10,720 -13.6%
9.06
US$97,127 		10,720 -13.6% 9.06 US$97,127
2025-12-17 2025-12-16 S Sale
2.2
Multani Pratik S

Chief Medical Officer

Officer
10,720 -13.6%
9.06
US$97,129 		10,720 -13.6% 9.06 US$97,129
2025-12-17 2025-12-16 S Sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
33,374 -5.4%
9.06
US$302,368 		33,374 -5.4% 9.06 US$302,368
2025-12-16 2025-12-16 PrS Proposed sale
2.2
Piscitelli Dominic

Officer

Officer
10,720
9.06
US$97,128 		10,720 9.06 US$97,128
2025-12-16 2025-12-16 PrS Proposed sale
3.1
Chacko Jacob

Officer; Director

Executive Director
33,374
9.06
US$302,370 		33,374 9.06 US$302,370
2025-12-16 2025-12-16 PrS Proposed sale
2.2
Multani Pratik S

Officer

Officer
10,720
9.06
US$97,129 		10,720 9.06 US$97,129
2025-10-08 2025-10-06 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
37,461 -6.6%
12.32
US$461,520 		37,461 -6.6% 12.32 US$461,520
2025-10-08 2025-10-06 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
11,000 -18.5%
14.52
US$159,719 		11,000 -18.5% 14.52 US$159,719
2025-10-06 2025-10-06 PrS Proposed sale
2.2
Dominic Piscitelli

Officer

Officer
50,000
14.50
US$725,000 		50,000 14.50 US$725,000
2025-10-02 2025-10-01 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
53,001 -8.5%
12.05
US$638,805 		53,001 -8.5% 12.05 US$638,805
2025-10-02 2025-09-30 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
34,538 -5.3%
12.01
US$414,750 		34,538 -5.3% 12.01 US$414,750
2025-09-24 2025-09-22 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
125,000 -16.0%
10.80
US$1,349,938 		125,000 -16.0% 10.80 US$1,349,938
2025-09-22 2025-09-22 PrS Proposed sale
3.1
Jacob Chacko

Director; Officer

Executive Director
250,000
10.50
US$2,625,000 		250,000 10.50 US$2,625,000
2025-07-02 2025-07-01 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
20,000 -29.3%
10.05
US$200,972 		20,000 -29.3% 10.05 US$200,972
2025-06-24 2025-06-24 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
32,466 -32.2%
10.50
US$341,039 		32,466 -32.2% 10.50 US$341,039
2025-06-24 2025-06-23 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
450 -0.4%
10.01
US$4,504 		450 -0.4% 10.01 US$4,504
2025-06-24 2025-06-23 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
584 -0.6%
10.00
US$5,840 		584 -0.6% 10.00 US$5,840
2025-06-23 2025-06-23 B Purchase
3.5
You Angie
Non-Executive Director
1,403 +5.3%
9.43
US$13,230 		1,403 +5.3% 9.43 US$13,230
2025-06-23 2025-06-20 B Purchase
3.5
You Angie
Non-Executive Director
26,597 +inf%
9.39
US$249,669 		26,597 +inf% 9.39 US$249,669
2025-06-13 2025-06-12 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
300 -0.3%
10.00
US$3,000 		300 -0.3% 10.00 US$3,000
2025-06-11 2025-06-11 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
1,700 -1.6%
10.01
US$17,017 		1,700 -1.6% 10.01 US$17,017
2025-06-11 2025-06-11 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
1,276 -1.2%
10.00
US$12,760 		1,276 -1.2% 10.00 US$12,760
2025-06-11 2025-06-10 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
324 -0.3%
10.00
US$3,240 		324 -0.3% 10.00 US$3,240
2025-06-09 2025-06-09 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
300 -0.3%
10.00
US$3,000 		300 -0.3% 10.00 US$3,000
2025-06-09 2025-06-06 PlS Planned sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
2,600 -2.4%
10.01
US$26,021 		2,600 -2.4% 10.01 US$26,021
2025-06-06 2025-06-06 PrS Proposed sale
2.2
Dominic Piscitelli

Officer

Officer
60,000
9.00
US$540,000 		60,000 9.00 US$540,000
2024-12-17 2024-12-16 S Sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
8,851 -7.7%
8.28
US$73,298 		8,851 -7.7% 8.28 US$73,298
2024-12-17 2024-12-16 S Sale
2.2
Multani Pratik S

Chief Medical Officer

Officer
8,850 -15.9%
8.28
US$73,293 		8,850 -15.9% 8.28 US$73,293
2024-12-17 2024-12-16 S Sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
24,660 -3.1%
8.28
US$204,214 		24,660 -3.1% 8.28 US$204,214
2024-12-16 2024-12-16 PrS Proposed sale
2.2
Multani Pratik S

Officer

Officer
8,850
8.28
US$73,294 		8,850 8.28 US$73,294
2024-12-16 2024-12-16 PrS Proposed sale
3.1
Chacko Jacob

Officer; Director

Executive Director
24,660
8.28
US$204,215 		24,660 8.28 US$204,215
2024-12-16 2024-12-16 PrS Proposed sale
2.2
Piscitelli Dominic

Officer

Officer
8,851
8.28
US$73,298 		8,851 8.28 US$73,298
2024-03-08 2024-03-06 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
40,000 -5.2%
16.21
US$648,380 		40,000 -5.2% 16.21 US$648,380
2024-03-06 2024-03-06 PrS Proposed sale
3.1
Jacob Chacko

Director

Non-Executive Director
40,000
16.21
US$648,380 		40,000 16.21 US$648,380
2024-02-08 2024-02-07 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
26,042 -3.3%
12.30
US$320,186 		26,042 -3.3% 12.30 US$320,186
2024-02-08 2024-02-06 PlS Planned sale
3.1
Chacko Jacob

PRESIDENT AND CEO

Executive Director
13,958 -1.7%
12.12
US$169,160 		13,958 -1.7% 12.12 US$169,160
2024-02-06 2024-02-06 PrS Proposed sale
3.1
Jacob Chacko

Director

Non-Executive Director
40,000
12.00
US$480,000 		40,000 12.00 US$480,000
2023-12-19 2023-12-15 S Sale
3.1
Chacko Jacob

President and CEO

Executive Director
14,539 -1.8%
8.58
US$124,813 		14,539 -1.8% 8.58 US$124,813
2023-12-19 2023-12-15 S Sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
5,282 -5.9%
8.58
US$45,338 		5,282 -5.9% 8.58 US$45,338
2023-12-19 2023-12-15 S Sale
2.2
Multani Pratik S

Chief Medical Officer

Officer
5,282 -18.2%
8.59
US$45,351 		5,282 -18.2% 8.59 US$45,351
2023-07-11 2023-07-11 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
5,156 -0.7%
8.01
US$41,287 		5,156 -0.7% 8.01 US$41,287
2023-07-11 2023-07-10 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
10,508 -1.3%
8.01
US$84,212 		10,508 -1.3% 8.01 US$84,212
2023-07-07 2023-07-05 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
4,336 -0.5%
8.01
US$34,711 		4,336 -0.5% 8.01 US$34,711
2023-07-05 2023-07-05 PrS Proposed sale
3.1
Jacob Chacko

Director

Non-Executive Director
20,000
8.00
US$160,000 		20,000 8.00 US$160,000
2023-06-28 2023-06-26 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
20,000 -2.4%
8.03
US$160,562 		20,000 -2.4% 8.03 US$160,562
2023-06-26 2023-06-26 PrS Proposed sale
3.1
Jacob Chacko

Affiliate
20,000
8.03
US$160,561 		20,000 8.03 US$160,561
2022-12-16 2022-12-15 S Sale
2.2
Multani Pratik S

Chief Medical Officer

Officer
2,089 -22.0%
3.25
US$6,789 		2,089 -22.0% 3.25 US$6,789
2022-12-16 2022-12-15 S Sale
2.2
Piscitelli Dominic

Chief Financial Officer

Officer
2,089 -3.0%
3.25
US$6,789 		2,089 -3.0% 3.25 US$6,789
2022-12-16 2022-12-15 S Sale
3.1
Chacko Jacob

President and CEO

Executive Director
5,764 -0.7%
3.25
US$18,733 		5,764 -0.7% 3.25 US$18,733
2022-05-13 2022-05-13 B Purchase
3.1
Chacko Jacob

President and CEO

Executive Director
76,072 +10.5%
2.82
US$214,561 		76,072 +10.5% 2.82 US$214,561
2022-05-13 2022-05-12 B Purchase
3.1
Chacko Jacob

President and CEO

Executive Director
69,354 +10.6%
2.75
US$190,467 		69,354 +10.6% 2.75 US$190,467
2022-05-13 2022-05-11 B Purchase
3.1
Chacko Jacob

President and CEO

Executive Director
304,574 +86.4%
2.90
US$883,569 		304,574 +86.4% 2.90 US$883,569
2022-03-25 2022-03-25 B Purchase
3.1
Chacko Jacob

President and CEO

Executive Director
50,000 +16.5%
4.54
US$227,170 		50,000 +16.5% 4.54 US$227,170
2022-03-25 2022-03-24 B Purchase
3.1
Chacko Jacob

President and CEO

Executive Director
42,873 +16.5%
5.03
US$215,660 		42,873 +16.5% 5.03 US$215,660
2022-03-25 2022-03-23 B Purchase
3.1
Chacko Jacob

President and CEO

Executive Director
257,127 +9695.6%
4.98
US$1,280,878 		257,127 +9695.6% 4.98 US$1,280,878
2021-09-14 2021-09-13 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
2,801 -20.6%
25.02
US$70,089 		2,801 -20.6% 25.02 US$70,089
2021-09-14 2021-09-13 PlS Planned sale
Heyman Richard A.
Non-Executive Director
601 -0.3%
25.01
US$15,033 		601 -0.3% 25.01 US$15,033
2021-09-14 2021-09-10 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
2,942 -17.8%
25.08
US$73,783 		2,942 -17.8% 25.08 US$73,783
2021-09-14 2021-09-10 PlS Planned sale
Heyman Richard A.
Non-Executive Director
479 -0.2%
25.10
US$12,023 		479 -0.2% 25.10 US$12,023
2021-05-28 2021-05-27 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
400 -1.7%
25.07
US$10,028 		400 -1.7% 25.07 US$10,028
2021-05-24 2021-05-24 PlS Planned sale
2.4
SCHELLER RICHARD H
Non-Executive Director
100 -0.3%
25.00
US$2,500 		100 -0.3% 25.00 US$2,500
2021-05-24 2021-05-24 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
12 -0.1%
25.00
US$300 		12 -0.1% 25.00 US$300
2021-05-24 2021-05-21 PlS Planned sale
2.4
SCHELLER RICHARD H
Non-Executive Director
1,231 -3.0%
25.19
US$31,008 		1,231 -3.0% 25.19 US$31,008
2021-05-24 2021-05-21 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
4,790 -17.1%
25.20
US$120,688 		4,790 -17.1% 25.20 US$120,688
2021-05-24 2021-05-20 PlS Planned sale
2.4
SCHELLER RICHARD H
Non-Executive Director
659 -1.6%
25.08
US$16,528 		659 -1.6% 25.08 US$16,528
2021-05-24 2021-05-20 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
2,468 -8.1%
25.07
US$61,864 		2,468 -8.1% 25.07 US$61,864
2021-05-18 2021-05-18 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
200 -0.7%
26.03
US$5,206 		200 -0.7% 26.03 US$5,206
2021-05-18 2021-05-18 PlS Planned sale
3.1
Chacko Jacob

President and CEO

Executive Director
11,132 -26.7%
25.37
US$282,428 		11,132 -26.7% 25.37 US$282,428
2021-05-18 2021-05-18 PlS Planned sale
Heyman Richard A.
Non-Executive Director
2,161 -1.0%
25.32
US$54,715 		2,161 -1.0% 25.32 US$54,715
Explore more

More insider trading research around Oric Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America